Journal of Clinical and Cellular Immunology
Open Access
ISSN: 2155-9899
+44 1223 790975
ISSN: 2155-9899
+44 1223 790975
Shubham Goel, Biman Saikia, Deepti Suri, Ranjana W. Minz and Surjit Singh
Posters: J Clin Cell Immunol
Introduction: The Hyper-IgE Syndrome (HIES),caused by mutation in STAT 3 gene accounts for the majority of the autosomal dominant (AD) and sporadic forms of HIES. AD-HIES is associated with skeletal and dental abnormalitiesin addition to immunological defects.Mice deficient in Cathepsin E has been observed to spontaneously develop features of atopic dermatitis very similar to human AD while Cathepsin K dysregulation has been observed to havesimilar skeletal defects including double row of teeth. Objective: To correlate cathepsin E and K expression with skin and skeletal manifestations in HIES patients. Material and Methods: Fifteen clinically suspected HIES patients were recruited based on NIH Scoring. STAT 3 sequencing, T H 17 cells (CD4 + IL - 17 + IFN-γ - )and phospho-STAT3 analysis was performed among the patients of HIES and healthy controls. Patients were classified intoMutation negative [n=11]and Mutation positive [n=4].PBMCs from patients and controls were stimulated with IL-6 (30 ng/ml) for 24 hr followed by total RNA isolation. qPCRwas performed for Cathepsin K and Cathepsin E expression using relative quantification method. Results: Mutation was found in 4 out of 15 clinical suspected HIES.Mutation positive patients had significantly decreased T H 17 cells compared to healthy controls andMutation negative patients.STAT3 phosphorylation was also found to be abnormal in Mutation positive patients. Expression of Cathepsin K and E wassimilar in controls and Mutation negative patientsafter stimulation however Mutation positive patients showed variable expression of cathepsin K and E . Conclusion: STAT3 signaling through IL-6 does not seem to play a role in regulation of Cathpesin K and E expression.
Shubham Goel has completed bachelor degree in Microbiology (H) from Delhi University in 2008 and Master degree in Medical Biotechnology from PGIMER, Chandigarh in 2010. Now pursuing PhD in the field of Immunodeficiency at the age of 26 years from the department of Immunopathology, PGIMER, Chandigarh, India.He has been awarded with NET-CSIR (LS), ICMR and PGI fellowship and life member of India Society for Primary Immune Deficiency (ISPID) and Indian Immunology Society (IIS). He has presented posters and oral paper in various national and international conferences. He has published two papers in peer reviewed journals.